Georgetown University School of Medicine, Washington, DC
University of Illinois at Urbana-Champaign, Urbana, IL
Clinical Fellow in Gastroenterology, Department of Medicine
Fellow in Gastroenterology
Research Fellow in Gastroenterology/Senior Assistant Resident in Medicine
Junior Assistant Resident in Medicine
Intern in Medicine
Duke University Medical Center, Durham, NC
Postdoctoral Fellow, Department of Pharmacology
University of Miami Miller School of Medicine, Miami, FL
Allen Mangel, MD, PhD, is a gastroenterologist and Executive Vice President of RTI-HS. Following completion of his medical training, Dr. Mangel did his internship and residency in internal medicine at Duke University Medical Center and then completed his gastroenterology fellowship also at Duke. Following completion of his formal training, he remained on the faculty in the Department of Medicine, Division of Gastroenterology, at Duke for 2 years. Dr. Mangel also has a PhD from the University of Illinois, where his research focused on control of electrical and mechanical activity in gastrointestinal smooth muscle.
After Dr. Mangel left Duke, he joined the gastroenterology clinical research department at GlaxoWellcome, where he conducted numerous clinical trials and directed product development teams. After departing GlaxoWellcome, he became Vice President of Research and Development at Salix Pharmaceuticals. He joined RTI International in 2003 and currently serves as Executive Vice President of RTI-HS. Dr. Mangel has led or participated in numerous FDA interactions, advisory committee presentations, label negotiations, and new drug application submissions, and he has authored more than 100 publications.